In PWS, the genetic alteration involves the RASA1 gene encoding Ras p21 protein activator 1, involved in capillary malformation–arteriovenous malformation (CM-AVM) syndrome (105). This evidence concerns the gene RASA1 and capillary malformation-arteriovenous malformation syndrome.